Colgate-Palmolive Company (CL) Given Consensus Recommendation of “Hold” by Brokerages
Colgate-Palmolive Company (NYSE:CL) has received a consensus rating of “Hold” from the eighteen brokerages that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $74.81.
Several research firms recently weighed in on CL. BidaskClub cut shares of Colgate-Palmolive Company from a “hold” rating to a “sell” rating in a report on Saturday. Citigroup Inc. restated a “neutral” rating and set a $76.00 price target (up from $75.00) on shares of Colgate-Palmolive Company in a report on Friday, April 7th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive Company in a report on Thursday, May 25th. JPMorgan Chase & Co. began coverage on shares of Colgate-Palmolive Company in a report on Tuesday, March 21st. They set a “neutral” rating and a $77.00 price target on the stock. Finally, Zacks Investment Research upgraded shares of Colgate-Palmolive Company from a “sell” rating to a “hold” rating in a report on Friday, March 17th.
Colgate-Palmolive Company (NYSE CL) traded down 0.04% during midday trading on Monday, reaching $75.89. The company had a trading volume of 1,906,668 shares. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The firm has a market capitalization of $67.03 billion, a P/E ratio of 27.39 and a beta of 0.82. The stock’s 50 day moving average price is $74.49 and its 200-day moving average price is $71.10.
Colgate-Palmolive Company (NYSE:CL) last released its quarterly earnings results on Friday, April 28th. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.01. Colgate-Palmolive Company had a net margin of 16.31% and a return on equity of 3,725.55%. The business had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.80 billion. During the same period in the previous year, the company earned $0.63 earnings per share. The firm’s revenue for the quarter was up .0% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post $2.92 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive Company’s payout ratio is 57.76%.
In other news, VP Daniel B. Marsili sold 14,000 shares of the business’s stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $73.97, for a total value of $1,035,580.00. Following the sale, the vice president now owns 73,904 shares of the company’s stock, valued at $5,466,678.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $75.67, for a total transaction of $290,043.11. Following the completion of the sale, the insider now directly owns 53,022 shares in the company, valued at approximately $4,012,174.74. The disclosure for this sale can be found here. Over the last quarter, insiders sold 43,666 shares of company stock worth $3,184,972. Corporate insiders own 1.02% of the company’s stock.
Several hedge funds have recently bought and sold shares of CL. Private Advisor Group LLC raised its stake in Colgate-Palmolive Company by 19.6% in the fourth quarter. Private Advisor Group LLC now owns 60,893 shares of the company’s stock valued at $3,977,000 after buying an additional 9,970 shares during the period. Concentric Wealth Management LLC acquired a new stake in Colgate-Palmolive Company during the fourth quarter valued at about $559,000. Honkamp Krueger Financial Services Inc. ADV acquired a new stake in Colgate-Palmolive Company during the fourth quarter valued at about $1,260,000. Prudential PLC raised its stake in Colgate-Palmolive Company by 13.9% in the fourth quarter. Prudential PLC now owns 745,362 shares of the company’s stock valued at $48,777,000 after buying an additional 91,100 shares during the period. Finally, Analyst IMS Investment Management Services Ltd. raised its stake in Colgate-Palmolive Company by 6.0% in the fourth quarter. Analyst IMS Investment Management Services Ltd. now owns 4,449 shares of the company’s stock valued at $291,000 after buying an additional 250 shares during the period. 74.13% of the stock is currently owned by institutional investors.
Colgate-Palmolive Company Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.